Deutsche Bank’s Impax Laboratories, Inc. IPXL Stock Holding History

Deutsche Bank's IPXL Position: Q2 2018 in Review

Deutsche Bank sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 261,382 shares — an estimated $5.08M sold.

Deutsche Bank first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $31.6M in Q4 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

• Deutsche Bank reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
• Deutsche Bank sold 261,382 Impax Laboratories, Inc. shares in Q2 2018, an estimated $5.08M.
• Deutsche Bank first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
• Deutsche Bank's Impax Laboratories, Inc. position peaked at $31.6M in Q4 2015.
• 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Deutsche Bank's 13F filing for Q2 2018, filed 14 Aug 2018.